Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been admitted to hospital with a main diagnosis of acute decompensated heart failure (a sudden worsening of heart failure symptoms), confirmed using a standard set of medical criteria called the modified Framingham criteria
Who may not be able to join:
- People who are unable to provide blood samples or cannot attend follow-up appointments
- People with severe kidney problems (confirmed with trial site for specific lab values)
- People with significant liver problems, where liver test results are more than 2.5 times the normal range
- People with severe lung problems, where breathing test results fall below 50% of what is expected for their age and size
- People who need a breathing tube to help them breathe
- People whose heart failure blood marker (called NTproBNP) is measured above a very high level at the time of admission (confirm specific threshold with trial site)
- People who are already on a waiting list for a heart transplant, or who have been admitted specifically to be assessed for a transplant
- People who are in cardiogenic shock (when the heart is suddenly unable to pump enough blood to meet the body's needs)
- People with a life expectancy of less than 6 months, or those with serious additional illnesses such as a recent stroke, cancer, pneumonia, or another life-threatening condition
- People whose situation makes it difficult to be discharged from hospital, such as those who have had a fall or who are waiting for a long-term care placement
- People with any other significant condition that the trial doctor believes could put them at risk, affect the trial results, or affect their ability to take part
- People who have taken part in another clinical trial involving an experimental treatment within the past 30 days
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Peter Liu, MD, Ottawa Heart Institute Research Corporation
Phone: 613-696-7000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
the total number of days alive and out of hospital during the first 30 days of heart failure diagnosis; the total number of days alive and out of hospital during the first 30 days of heart failure diagnosis; the total number of days alive and out of hospital during the first 30 days of heart failure diagnosis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.